XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
EARNINGS PER SHARE (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Numerator [Abstract]                
Net income (loss) $ 723 $ (589) $ 645 $ (16) $ 540 $ 745 $ 779 $ 1,269
Denominator [Abstract]                
Basic weighted-average common shares outstanding (in shares) 8,235,610     8,663,921     8,361,959 8,712,939
Diluted weighted-average common shares outstanding (in shares) 8,272,557 [1]     8,663,921 [1]     8,383,558 8,718,068
Net income (loss) per common share, basic [Abstract]                
Basic (in dollars per share) $ 0.09     $ 0     $ 0.09 $ 0.15
Net income (loss) per common share, diluted [Abstract]                
Diluted (in dollars per share) $ 0.09     $ 0     $ 0.09 $ 0.15
Shares excluded from the diluted EPS calculation (in shares) 178     15,326        
Restricted Stock [Member] | Board of Directors [Member]                
Denominator [Abstract]                
Dilutive effect of service-based restricted stock awards granted to Board of Directors under the Plan (in shares) 8,858     0     7,208 5,129
Restricted Stock [Member] | Employees [Member]                
Denominator [Abstract]                
Dilutive effect of service-based restricted stock awards granted to Board of Directors under the Plan (in shares) 28,089     0     14,391 0
[1] (1)  For the three months ended September 30, 2022, there were 178 shares excluded from the diluted EPS calculation, because the impact of their assumed vesting would be anti-dilutive. For the three months ended September 30, 2021, there were 15,326 shares excluded from the diluted EPS calculation, because the impact of their assumed vesting would be anti-dilutive due to a net loss in that period.